Stay updated on Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.

Latest updates to the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA 403 Forbidden error page appears when loading the study record, replacing the previous study details and navigation. This indicates an access restriction or server issue rather than a content update.SummaryDifference21%

- Check49 days agoChange DetectedThe page now displays Revision: v3.6.6 instead of v3.6.5, indicating a newer build of the page.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page shows a new revision marker (v3.6.5) replacing the previous one, indicating a small site update without changing the study information.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.6.4 replaces v3.6.3, indicating the page version was updated. This is a metadata update rather than a content change.SummaryDifference0.1%

- Check106 days agoChange DetectedThe page now shows a new revision tag v3.6.3, replacing the previous v3.6.2. This indicates a small update to the page's metadata/versioning without changes to the study data or visible content.SummaryDifference0.1%

Stay in the know with updates to Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.